These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 2329516)

  • 1. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
    López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
    J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor mediates glycerol-induced acute renal failure in rats.
    López-Farré A; Gómez-Garre D; Bernabeu F; Ramón y Cajal S; Perez-Rodrigo P; Braquet P; López-Novoa JM
    Clin Sci (Lond); 1990 Dec; 79(6):551-8. PubMed ID: 2176942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of platelet-activating factor-induced acute renal failure by BN 52021.
    Pirotzky E; Colliez P; Guilmard C; Schaeverbeke J; Mencia-Huerta JM; Braquet P
    Br J Exp Pathol; 1988 Apr; 69(2):291-9. PubMed ID: 3377967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelet activating factor in endotoxemic acute renal failure in the male rat.
    Tolins JP; Vercellotti GM; Wilkowske M; Ha B; Jacob HS; Raij L
    J Lab Clin Med; 1989 Mar; 113(3):316-24. PubMed ID: 2538527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021.
    Fernandez-Gallardo S; Cano E; Braquet P; Sanchez Crespo M
    Int J Immunopharmacol; 1988; 10(4):353-60. PubMed ID: 3139574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats.
    Rodriguez-Barbero A; López-Novoa JM; Arévalo M
    Exp Nephrol; 1997; 5(1):47-54. PubMed ID: 9052848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
    Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
    Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
    Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C
    Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
    Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
    Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity.
    Dos Santos OF; Boim MA; Barros EJ; Schor N
    Kidney Int; 1991 Oct; 40(4):742-7. PubMed ID: 1745025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of PAF-acether on the dog kidney.
    Hébert RL; Sirois P; Braquet P; Plante GE
    Prostaglandins Leukot Med; 1987 Mar; 26(3):189-202. PubMed ID: 3033688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for endothelin in the maintenance of post-ischaemic renal failure in the rat.
    López-Farré A; Gómez-Garre D; Bernabeu F; López-Novoa JM
    J Physiol; 1991 Dec; 444():513-22. PubMed ID: 1822562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the specific antagonist of PAF-acether, BN 52021, and of Ginkgo extract on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB2.
    Becker K; Braquet P; Förster W
    Biomed Biochim Acta; 1988; 47(10-11):S165-8. PubMed ID: 3073760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021.
    Baranes J; Hellegouarch A; Le Hegarat M; Viossat I; Auguet M; Chabrier PE; Braquet P
    Pharmacol Res Commun; 1986 Aug; 18(8):717-37. PubMed ID: 3763677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury.
    Plante GE; Sirois P; Braquet P
    Prostaglandins Leukot Essent Fatty Acids; 1988 Oct; 34(1):53-60. PubMed ID: 3231663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
    Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
    Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease.
    Wallace JL; Braquet P; Ibbotson GC; MacNaughton WK; Cirino G
    J Lipid Mediat; 1989; 1(1):13-23. PubMed ID: 2519884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.